Literature DB >> 7926690

The Brucella abortus vaccine strain B19 carries a deletion in the erythritol catabolic genes.

F J Sangari1, J M García-Lobo, J Agüero.   

Abstract

Brucella abortus B19, an avirulent strain obtained by spontaneous mutation, is used worldwide as a vaccine for the control of bovine brucellosis. B19 differs from other B. abortus strains in its sensitivity to erythritol. We took advantage of a previously obtained erythritol sensitive Tn5 insertion mutant of B. abortus 2308 to clone the chromosomal region containing erythritol catabolic genes from this representative pathogenic strain and from the vaccine strain B19. Physical mapping with restriction endonucleases and nucleotide sequence determination revealed the existence of a 702 bp long deletion, occurring between two short direct repeats, in the chromosome of B19. This deletion rendered the B19 strain sensitive to erythritol. Two oligonucleotides whose sequences flank this deletion provided an easy method to differentiate B19 from all other B. abortus isolates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926690     DOI: 10.1111/j.1574-6968.1994.tb07123.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  33 in total

1.  Regulation of Brucella abortus catalase.

Authors:  J A Kim; Z Sha; J E Mayfield
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Functional mapping of Brucella abortus cyclic beta-1,2-glucan synthase: identification of the protein domain required for cyclization.

Authors:  L Soledad Guidolin; Andrés E Ciocchini; Nora Iñón de Iannino; Rodolfo A Ugalde
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

3.  Evaluation of a multiplex PCR assay (Bruce-ladder) for molecular typing of all Brucella species, including the vaccine strains.

Authors:  I López-Goñi; D García-Yoldi; C M Marín; M J de Miguel; P M Muñoz; J M Blasco; I Jacques; M Grayon; A Cloeckaert; A C Ferreira; R Cardoso; M I Corrêa de Sá; K Walravens; D Albert; B Garin-Bastuji
Journal:  J Clin Microbiol       Date:  2008-08-20       Impact factor: 5.948

4.  High level of B19 strain detection in Brazilian cattle semen.

Authors:  M P S Lourencetti; M A Souza; M R Ganda; J P Santos; A Ferreira Júnior; S Miyashiro; A M C Lima
Journal:  Trop Anim Health Prod       Date:  2017-10-29       Impact factor: 1.559

5.  The Brucella abortus cyclic beta-1,2-glucan virulence factor is substituted with O-ester-linked succinyl residues.

Authors:  Mara S Roset; Andrés E Ciocchini; Rodolfo A Ugalde; Nora Iñón de Iannino
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

6.  Rapid and reliable single nucleotide polymorphism-based differentiation of Brucella live vaccine strains from field strains.

Authors:  Krishna K Gopaul; Jessica Sells; Betsy J Bricker; Oswald R Crasta; Adrian M Whatmore
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

7.  Genome structure and phylogeny in the genus Brucella.

Authors:  S Michaux-Charachon; G Bourg; E Jumas-Bilak; P Guigue-Talet; A Allardet-Servent; D O'Callaghan; M Ramuz
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

8.  Membrane topology analysis of cyclic glucan synthase, a virulence determinant of Brucella abortus.

Authors:  Andrés E Ciocchini; Mara S Roset; Nora Iñón de Iannino; Rodolfo A Ugalde
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

9.  Molecular cloning and characterization of cgs, the Brucella abortus cyclic beta(1-2) glucan synthetase gene: genetic complementation of Rhizobium meliloti ndvB and Agrobacterium tumefaciens chvB mutants.

Authors:  N Iñón de Iannino; G Briones; M Tolmasky; R A Ugalde
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

10.  Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes.

Authors:  J Pizarro-Cerdá; S Méresse; R G Parton; G van der Goot; A Sola-Landa; I Lopez-Goñi; E Moreno; J P Gorvel
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.